Literature DB >> 20438398

Enhanced reactivity of peripheral blood immune cells to HSV-1 in primary achalasia.

Kar W Lau1, Conal McCaughey, Peter V Coyle, Liam J Murray, Brian T Johnston.   

Abstract

OBJECTIVE: Achalasia is the best characterized oesophageal motor disorder but the etiology is unknown. The pathology is characterized by a decrease in nitric oxide-producing neurons and the presence of an activated T-cell inflammatory infiltrate in the myenteric plexus that are reactive to HSV-1 viral antigens. These findings are not present in normal controls. The current study compared the reactivity of peripheral blood mononuclear cells (PBMCs) between patients with primary achalasia and normal controls to determine if PBMCs of patients exhibit a similar heightened reactivity to the virus.
MATERIAL AND METHODS: Whole blood culture experiments were conducted with heparinized peripheral venous blood obtained from 151 patients with primary achalasia and 118 healthy controls. Whole blood was cultured in the presence of ultraviolet inactivated HSV-1 or conditioned cell culture media. Reactivity of mononuclear cells to viral antigens was quantified by measuring expression of the cytokine gene interferon-gamma using Taqman real-time polymerase chain reaction. Data are expressed as cytokine fold change corresponding to ratio of interferon-gamma messenger RNA copies produced in antigen stimulated versus unstimulated cells.
RESULTS: The interferon-gamma fold change was higher in cases 61.33 (20.54-217.00) than controls 49.67 (10.05-157.05). Mean fold change difference between cases and controls was 1.66 times (95% confidence interval 1.17-2.34, p = 0.004).
CONCLUSIONS: These results indicate that the PBMCs of patients with primary achalasia show an enhanced immune response to HSV-1 antigens. The data suggest that there is persistent stimulation of immune cells by herpes simplex virus type 1 (HSV-1) or HSV-1 like antigen moieties.

Entities:  

Mesh:

Year:  2010        PMID: 20438398     DOI: 10.3109/00365521003587804

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

1.  Socio-economic status and lifestyle factors are associated with achalasia risk: A population-based case-control study.

Authors:  Helen G Coleman; Ronan T Gray; Kar W Lau; Conall McCaughey; Peter V Coyle; Liam J Murray; Brian T Johnston
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

Review 2.  Achalasia: a review of clinical diagnosis, epidemiology, treatment and outcomes.

Authors:  Orla M O'Neill; Brian T Johnston; Helen G Coleman
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

3.  Focal achalasia - case report and review of the literature.

Authors:  Marcus Joachim Herzig; Radu Tutuian
Journal:  Clujul Med       Date:  2018-01-15

4.  Expression and significance of interleukin-17 and interleukin-22 in the serum and the lower esophageal sphincter of patients with achalasia.

Authors:  Zeyu Wang; Jun Zhang; Jianwei Mi; Huihui Ma; Dongqiang Zhao
Journal:  Saudi J Gastroenterol       Date:  2018 Jul-Aug       Impact factor: 2.485

5.  HSV1/2 Genital Infection in Mice Cause Reversible Delayed Gastrointestinal Transit: A Model for Enteric Myopathy.

Authors:  Arun Chaudhury; Vijaya Sena Reddy Dendi; Mousumi Chaudhury; Astha Jain; Madhukar Reddy Kasarla; Kiran Panuganti; Gaurav Jain; Abhijit Ramanujam; Bhavin Rena; Sudheer Reddy Koyagura; Sumit Fogla; Sunil Kumar; Nawal Singh Shekhawat; Srinivas Maddur
Journal:  Front Med (Lausanne)       Date:  2018-07-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.